Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Once-weekly injectable suspension can provide as much benefit as traditional twice-daily dosing.
Read More »Safety and Efficacy of a New Long-Acting Exenatide Formulation: BYDUREON® BCise™
Efficacy And Safety When Adding Ertugliflozin to Metformin and Sitagliptin
New SGLT-2 inhibitor can be used as add-on therapy to provide better improvement in HbA1C in patients with type 2 diabetes.
Read More »Real-World Benefits for SGLT-2 Inhibitors
Patients with type 2 diabetes usually do not die from diabetes, but from cardiovascular disease and strokes.
Read More »Omega-6 Fatty Acid Reduces Risk of Type 2 Diabetes
Study finds linoleic acid has long-term benefits in diabetes prevention, arachidonic acid not harmful.
Read More »Are Statins Related to Diabetes Progression?
Statin therapy may be elevating risk of type 2 diabetes in high-risk adults.
Read More »Semaglutide vs. Semaglutide in Treatment of Diabetes, Obesity
Study compares effectiveness of oral GLP-1 medication over injection.
Read More »Study Assesses Risk of Developing Diabetes, Reversing Prediabetes
Determining which patients benefit most from lifestyle, metformin interventions may improve individualized care decisions.
Read More »1-Hour Post-Prandial Glucose Predicts Risk For Type 2 Diabetes
Study finds diabetes complications and mortality may be better predicted with elevated 1-hour blood glucose levels compared with 2-hour blood glucose levels.
Read More »Hypoglycemia Linked to Increased Risk of Cardiovascular Dysfunction
Severe hypoglycemia in type 2 diabetes was found to be associated with increased cardiac failure and mortality.
Read More »Effect of Pioglitazone on Left Ventricular Diastolic Function
Diastolic function begins to decline in early stages of type 2 diabetes.
Read More »